William Walker

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

Wei Wu, H. Moebius, Andrée-Anne Berthiaume, 2022, Neurotherapeutics.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial

S. Hendrix, G. Viardot, H. Moebius, 2022, Journal of Alzheimer's disease : JAD.

Obstetrician-Gynecologist Views of Pregnancy-Related Medication Safety.

R. Blendon, S. Gilboa, G. Steelfisher, 2020, Journal of women's health.